Researchers comparing NAD+ and MOTS-c are usually mapping which compound fits a given cellular-metabolism research question. This is descriptive reference information about how they differ, not guidance or a recommendation. Both are sold strictly for in-vitro laboratory research and are not for human or veterinary use.
| NAD+ | MOTS-c | |
|---|---|---|
| Type | Redox coenzyme (small molecule) | 16-amino-acid mitochondrial-derived peptide |
| Primary research area | Sirtuin activity, redox metabolism, DNA repair | AMPK signaling, mitochondrial-nuclear crosstalk |
| Handling | Store frozen; reconstitute for cell-culture work | Lyophilized; store frozen |
NAD+ is a central redox coenzyme used as a reference compound in energy-metabolism, sirtuin, and cellular-aging research.
NAD+ product page and batch COA
MOTS-c is a mitochondrial-derived peptide studied in metabolic-signaling and AMPK-pathway research.
MOTS-c product page and batch COA · MOTS-c reconstitution guide
Both appear in metabolic research but at different levels: NAD+ as a coenzyme/substrate in redox and sirtuin studies, MOTS-c as a signaling peptide in mitochondrial-nuclear communication. The choice follows the mechanism under study.
NAD+ is a redox coenzyme studied in metabolism and sirtuin research; MOTS-c is a mitochondrial-derived signaling peptide studied in AMPK-pathway research. Different molecule types and roles.
Both feature in cellular-metabolism research, but they are structurally unrelated (a coenzyme vs. a peptide).
No. Both are sold strictly for in-vitro laboratory research and are not for human or veterinary use.